Antiretroviral drug combinations. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

CD4-Positive T-Lymphocytes Plasma Genitalia, Female Cell Line, Tumor Cell Line Cells, Cultured Leukocytes, Mononuclear CD8-Positive T-Lymphocytes Macrophages

Organisms7

HIV-1 HIV HIV-2 Simian immunodeficiency virus Macaca mulatta Plasmodium falciparum Mice, SCID

Diseases24

HIV Infections Acquired Immunodeficiency Syndrome Pregnancy Complications, Infectious AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome HIV Seropositivity Viremia HIV Wasting Syndrome Lipodystrophy Immune Reconstitution Inflammatory Syndrome AIDS Dementia Complex Tuberculosis Simian Acquired Immunodeficiency Syndrome Coinfection Disease Progression Lymphoma, AIDS-Related Drug-Related Side Effects and Adverse Reactions Cytomegalovirus Retinitis Neoplasms AIDS-Associated Nephropathy Acidosis, Lactic Malaria, Falciparum Malaria Substance Abuse, Intravenous

Chemicals and Drugs101

Anti-HIV Agents Anti-Retroviral Agents Drug Combinations Reverse Transcriptase Inhibitors HIV Protease Inhibitors Zidovudine Benzoxazines Nevirapine Lopinavir Indinavir Ritonavir Stavudine Organophosphonates HIV Reverse Transcriptase Lamivudine HIV Fusion Inhibitors Nelfinavir Adenine HIV Protease RNA, Viral Pyrimidinones Integrase Inhibitors Didanosine Saquinavir HIV Integrase Inhibitors Dideoxynucleosides pol Gene Products, Human Immunodeficiency Virus Oxazines Cyclohexanes Antiviral Agents Antitubercular Agents Drugs, Generic Pyrrolidinones Pyridines Zalcitabine Protease Inhibitors Drugs, Investigational Proguanil Methenamine Antimalarials HIV Envelope Protein gp41 Gene Products, pol Dapsone Receptors, CCR5 Artemisinins Antineoplastic Agents Triazoles Atovaquone Oligopeptides Methylthioinosine Cyclopentolate Tropicamide Cellophane DNA, Viral Rifampin Sulfamethoxazole Pyrimethamine AIDS Vaccines Deoxycytidine Mefloquine P-Glycoprotein HIV Antibodies Nanoconjugates Pharmaceutical Preparations Floxuridine Antifungal Agents Sulfadoxine Cisplatin Doxorubicin Pyrazines Amodiaquine Cytochrome P-450 CYP3A Amikacin Pyrimidines Fluorenes Chloroquine Phentermine Fluorouracil Sesquiterpenes Boronic Acids Naphthoquinones Piperazines HIV Envelope Protein gp120 Vincristine Sulfonamides Amphotericin B Antiprotozoal Agents Niacinamide Trimethoprim Anti-Bacterial Agents Phenylurea Compounds Ethambutol Cytarabine Quinolines Medetomidine Quinazolines Paclitaxel Nitroimidazoles Benzenesulfonates Antihypertensive Agents Etoposide

Analytical, Diagnostic and Therapeutic Techniques and Equipment49

Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Viral Load Drug Therapy, Combination Treatment Failure Treatment Outcome Cohort Studies Drug Administration Schedule Drug Monitoring Antineoplastic Combined Chemotherapy Protocols Microbial Sensitivity Tests Clinical Trials as Topic Prospective Studies Retrospective Studies Risk Factors Cross-Sectional Studies Drug Therapy Prevalence Lost to Follow-Up Longitudinal Studies Sequence Analysis, DNA Drug Screening Assays, Antitumor Follow-Up Studies Incidence Inhibitory Concentration 50 Directly Observed Therapy Drug Evaluation, Preclinical Models, Biological Nanoconjugates Logistic Models Chromatography, High Pressure Liquid Molecular Targeted Therapy Xenograft Model Antitumor Assays Kaplan-Meier Estimate Models, Statistical Amino Acid Substitution Drug Design Survival Analysis Parasitic Sensitivity Tests Withholding Treatment CD4-CD8 Ratio Drug Discovery Polymerase Chain Reaction Models, Theoretical Chemoprevention Clinical Trials, Phase I as Topic Drug Evaluation Multivariate Analysis Lymphocyte Count

Psychiatry and Psychology6

Medication Adherence Patient Compliance AIDS Dementia Complex Breast Feeding Treatment Refusal Substance Abuse, Intravenous

Phenomena and Processes34

Drug Resistance, Viral CD4 Lymphocyte Count Viral Load Drug Resistance, Multiple, Viral Drug Synergism Drug Interactions Mutation Virus Replication Genotype Time Factors Pregnancy Genes, pol Dose-Response Relationship, Drug Drug Resistance, Microbial HIV Seronegativity Mutation, Missense Drug Antagonism Breast Feeding Inhibitory Concentration 50 Drug Resistance Phylogeny Cell Survival Biological Availability Phenotype Apoptosis Genetic Variation Amino Acid Substitution Drug Resistance, Multiple Drug Resistance, Neoplasm CD4-CD8 Ratio Cell Proliferation Amino Acid Sequence Algorithms Lymphocyte Count

Disciplines and Occupations4

Drug Design Pharmacology Drug Discovery Systems Biology

Anthropology, Education, Sociology and Social Phenomena3

Developing Countries International Cooperation Treatment Refusal

Technology, Industry, Agriculture3

Cellophane Nanoconjugates Nanoparticles

Information Science6

Prevalence Incidence Molecular Sequence Data Phylogeny Amino Acid Sequence Algorithms

Named Groups2

Infant, Newborn HIV Long-Term Survivors

Health Care27

Infectious Disease Transmission, Vertical Treatment Failure Medication Adherence Treatment Outcome Cohort Studies Patient Compliance Commission on Professional and Hospital Activities Clinical Trials as Topic Prospective Studies Retrospective Studies Risk Factors Cross-Sectional Studies Prevalence Longitudinal Studies Follow-Up Studies Incidence Health Services Accessibility World Health Logistic Models Kaplan-Meier Estimate Models, Statistical Survival Analysis Withholding Treatment Sex Factors Treatment Refusal Clinical Trials, Phase I as Topic Multivariate Analysis

Geographicals18

South Africa Uganda Africa South of the Sahara Zimbabwe Malawi Botswana Brazil Cote d'Ivoire United States Zambia Africa, Southern France Lesotho Thailand Cameroon Kenya Rwanda Haiti

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Anti-HIV Agents Antiretroviral Therapy, Highly Active HIV Infections Anti-Retroviral Agents Drug Combinations Drug Resistance, Viral HIV-1 Reverse Transcriptase Inhibitors CD4 Lymphocyte Count Viral Load HIV Protease Inhibitors Drug Therapy, Combination Zidovudine Benzoxazines Drug Resistance, Multiple, Viral Nevirapine HIV Infectious Disease Transmission, Vertical Acquired Immunodeficiency Syndrome Lopinavir Indinavir Drug Synergism Ritonavir Drug Interactions Stavudine Organophosphonates HIV Reverse Transcriptase Lamivudine HIV Fusion Inhibitors Nelfinavir Pregnancy Complications, Infectious Adenine HIV Protease RNA, Viral Pyrimidinones South Africa Integrase Inhibitors Treatment Failure Medication Adherence Didanosine AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome Uganda Saquinavir Treatment Outcome HIV Seropositivity Cohort Studies Viremia Patient Compliance HIV Integrase Inhibitors Dideoxynucleosides Drug Administration Schedule Mutation pol Gene Products, Human Immunodeficiency Virus Africa South of the Sahara Virus Replication Genotype Drug Monitoring CD4-Positive T-Lymphocytes Oxazines HIV Wasting Syndrome Time Factors Cyclohexanes Zimbabwe Malawi Antiviral Agents Pregnancy Developing Countries Antitubercular Agents Antineoplastic Combined Chemotherapy Protocols Commission on Professional and Hospital Activities Drugs, Generic Genes, pol Pyrrolidinones Microbial Sensitivity Tests Lipodystrophy Dose-Response Relationship, Drug Plasma Pyridines Zalcitabine Protease Inhibitors Clinical Trials as Topic Drugs, Investigational Prospective Studies Retrospective Studies Proguanil Methenamine Antimalarials Risk Factors Cross-Sectional Studies Genitalia, Female Drug Therapy Immune Reconstitution Inflammatory Syndrome Prevalence HIV Envelope Protein gp41 Drug Resistance, Microbial Infant, Newborn Botswana Gene Products, pol Dapsone

No FAQ available that match "antiretroviral drug combinations"